Loading...
XASE
CATX
Market cap178mUSD
Dec 05, Last price  
2.40USD
1D
0.42%
1Q
-30.64%
Jan 2017
-58.62%
IPO
-82.86%
Name

IsoRay Inc

Chart & Performance

D1W1MN
XASE:CATX chart
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-0.96%
Rev. gr., 5y
-27.81%
Revenues
0k
-100.00%
1,994,3065,738,0337,158,6905,417,8155,286,0845,238,9735,071,0884,525,2334,219,1584,606,5394,769,2764,761,0005,923,0007,314,0009,680,00010,053,00010,795,0007,104,0001,434,0000
Net income
-79m
L+70.46%
-8,218,130-9,605,155-8,557,507-6,160,841-4,033,856-2,842,213-3,488,905-3,856,596-5,959,122-3,681,051-4,710,808-6,162,000-6,700,000-4,850,000-3,269,000-3,188,000-7,153,000-14,670,000-46,508,000-79,279,000
CFO
-18m
L-50.44%
-7,003,077-7,201,710-7,725,298-3,948,936-2,686,403-2,418,910-2,447,775-3,056,267-3,228,221-3,521,858-3,884,000-5,712,000-5,712,000-5,049,000-3,641,000-2,837,000-7,710,000-12,172,000-36,913,000-18,294,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
URL
https://isoray.com/
IPO date
May 31, 2002
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT